News
Zacks.com on MSN10h
MDGL Stock Soars 11% on New Patent Protecting Rezdiffra Dosing RightsMadrigal Pharmaceuticals stock jumps 11% after securing a new U.S. patent for Rezdiffra's dosing, reinforcing exclusivity ...
Investor's Business Daily on MSN11h
Madrigal Pharmaceuticals Hits 80-Plus Relative Strength Rating BenchmarkMadrigal Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 87.
Zacks.com on MSN15h
Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last?Madrigal (MDGL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback